These valuable caregivers do not need false claims, empty promises, or even more technology to stay on top of. They need access to health education and literacy, healthy food, and seamless self-efficacy tools. The post Despite Our Efforts, The Sandwich Generation is Still Missing These Key Ingredients appeared first on MedCity News.
Fidelity Management & Research Company and Dexcom participated in ŌURA’s $200 million Series D round. The post ŌURA Snags $200M, Hits $5.2B Valuation appeared first on MedCity News.
U.S. healthcare organizations lose $1.9 million on average during each day of downtime following a ransomware attack, according to new research from Comparitech. Rebecca Moody, Comparitech’s head of data research, predicted that the rate of ransomware attacks in the healthcare sector will accelerate even more in 2025. The post Healthcare Providers Lose Nearly $2M Per…
These benefits set employees up with the resources and access to manage their health efficiently and proactively while giving employers financial savings throughout the year. The post The Benefits Hierarchy of Needs: Why Employers & Payers Should Prioritize Gut Health Benefits appeared first on MedCity News.
The public health community can circle the wagons and complain about the attacking forces outside. Alternatively, public health advocates can take a hard look in the mirror, get outside of their bubble, frankly identify failures and missteps, and determine how to regain the trust of an increasingly skeptical public. The post Public Health’s Proudest Moment…
President-elect Donald Trump recently appointed former Paypal executive David Sacks as the White House’s first-ever czar for AI and cryptocurrency. Ryan Tarzy — CEO of Avandra Imaging, a federated network for de-identified imaging data — thinks this appointment could help accelerate the pace of innovation in the healthcare industry. The post Why One Startup CEO…
Corxel Pharmaceuticals has acquired an oral small molecule GLP-1 agonist with potential applications in obesity and diabetes. The Phase 2-ready pill could compete with oral metabolic meds in development by companies such as Roche, AstraZeneca, and Structure Therapeutics. The post The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender appeared first on…
Several healthcare provisions, including drug reforms, were left out of the government funding bill, angering some healthcare leaders. The post Healthcare Leaders Slam Exclusion of Key Healthcare Provisions in Spending Package appeared first on MedCity News.
Sotyktu, which became the first TYK2 inhibitor to reach the market after its 2022 FDA approval in plaque psoriasis, now has positive data from two pivotal tests in psoriatic arthritis. Bristol Myers Squibb is trying to add new indications for the drug and stay ahead of competitors including Takeda Pharmaceutical. The post Bristol Myers Squibb’s…
Ascension’s May cyberattack compromised 5.6 million patients’ personal and health information, including Social Security numbers, credit card numbers and addresses. However, there is no evidence that any data was stolen from Acension’s EHR or other clinical systems, the health system said. The post 5.6 Million Patients’ Data Stolen During Ascension’s Ransomware Attack Earlier This Year…